New Survey Finds NPs and PAs Shift Preferences for Engagement with Life Sciences Companies Amidst COVID-19
Point of Care Network (POCN), an NP and PA network, today released a new survey featuring how 153 NPs and PAs are engaging with life sciences companies in light of the COVID-19 pandemic. Some of the information touched on was the shifting roles and responsibilities of NPs and PAs, ideas to support them to improve patient care, and how they would like to receive communications.
The survey found that COVID-19 has significantly shifted both NPs’ and PAs’ roles and responsibilities. Not surprisingly, 95 percent of the respondents reported that telehealth has had a large impact on their interactions with patients.
Pre-pandemic, in a previous POCN survey, nearly 59 percent of the respondents used conferences to receive information from life sciences companies. In light of newly cancelled events, NPs and PAs are embracing virtual communications even more. In this new survey, the overwhelming majority wants to be reached electronically, through emails, journals, KOL webinars, and are open to virtual rep visits. Finally, the types of conference-style information they want to see most from life sciences companies are prescribing and treatment guidelines, patient assistance programs, disease info, samples, and copay cards.
For the full survey, click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
